The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biodegradable Hemostatic Agent-Global Market Insights and Sales Trends 2024
Synopsis
Biodegradable hemostatic agent is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period of time.
The global Biodegradable Hemostatic Agent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biodegradable Hemostatic Agent in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Biodegradable Hemostatic Agent market. Gauze, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biodegradable Hemostatic Agent, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biodegradable Hemostatic Agent market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biodegradable Hemostatic Agent market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biodegradable Hemostatic Agent sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biodegradable Hemostatic Agent covered in this report include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc.
The global Biodegradable Hemostatic Agent market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Global Biodegradable Hemostatic Agent market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biodegradable Hemostatic Agent market, Segment by Type:
Gauze
Powder
Gelatin Sponge
Other
Global Biodegradable Hemostatic Agent market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biodegradable Hemostatic Agent companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Biodegradable hemostatic agent is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period of time.
The global Biodegradable Hemostatic Agent market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biodegradable Hemostatic Agent in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Biodegradable Hemostatic Agent market. Gauze, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Powder segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biodegradable Hemostatic Agent, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biodegradable Hemostatic Agent market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biodegradable Hemostatic Agent market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biodegradable Hemostatic Agent sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biodegradable Hemostatic Agent covered in this report include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc.
The global Biodegradable Hemostatic Agent market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Global Biodegradable Hemostatic Agent market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biodegradable Hemostatic Agent market, Segment by Type:
Gauze
Powder
Gelatin Sponge
Other
Global Biodegradable Hemostatic Agent market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biodegradable Hemostatic Agent companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biodegradable Hemostatic Agent
1.1 Biodegradable Hemostatic Agent Market Overview
1.1.1 Biodegradable Hemostatic Agent Product Scope
1.1.2 Biodegradable Hemostatic Agent Market Status and Outlook
1.2 Global Biodegradable Hemostatic Agent Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biodegradable Hemostatic Agent Market Size by Region (2018-2029)
1.4 Global Biodegradable Hemostatic Agent Historic Market Size by Region (2018-2023)
1.5 Global Biodegradable Hemostatic Agent Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biodegradable Hemostatic Agent Market Size (2018-2029)
1.6.1 North America Biodegradable Hemostatic Agent Market Size (2018-2029)
1.6.2 Europe Biodegradable Hemostatic Agent Market Size (2018-2029)
1.6.3 Asia-Pacific Biodegradable Hemostatic Agent Market Size (2018-2029)
1.6.4 Latin America Biodegradable Hemostatic Agent Market Size (2018-2029)
1.6.5 Middle East & Africa Biodegradable Hemostatic Agent Market Size (2018-2029)
2 Biodegradable Hemostatic Agent Market by Type
2.1 Introduction
2.1.1 Gauze
2.1.2 Powder
2.1.3 Gelatin Sponge
2.1.4 Other
2.2 Global Biodegradable Hemostatic Agent Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biodegradable Hemostatic Agent Historic Market Size by Type (2018-2023)
2.2.2 Global Biodegradable Hemostatic Agent Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biodegradable Hemostatic Agent Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biodegradable Hemostatic Agent Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biodegradable Hemostatic Agent Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biodegradable Hemostatic Agent Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biodegradable Hemostatic Agent Revenue Breakdown by Type (2018-2029)
3 Biodegradable Hemostatic Agent Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Others
3.2 Global Biodegradable Hemostatic Agent Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biodegradable Hemostatic Agent Historic Market Size by Application (2018-2023)
3.2.2 Global Biodegradable Hemostatic Agent Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biodegradable Hemostatic Agent Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biodegradable Hemostatic Agent Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biodegradable Hemostatic Agent Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biodegradable Hemostatic Agent Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biodegradable Hemostatic Agent Revenue Breakdown by Application (2018-2029)
4 Biodegradable Hemostatic Agent Competition Analysis by Players
4.1 Global Biodegradable Hemostatic Agent Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biodegradable Hemostatic Agent as of 2022)
4.3 Date of Key Players Enter into Biodegradable Hemostatic Agent Market
4.4 Global Top Players Biodegradable Hemostatic Agent Headquarters and Area Served
4.5 Key Players Biodegradable Hemostatic Agent Product Solution and Service
4.6 Competitive Status
4.6.1 Biodegradable Hemostatic Agent Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnson
5.1.1 Johnson & Johnson Profile
5.1.2 Johnson & Johnson Main Business
5.1.3 Johnson & Johnson Biodegradable Hemostatic Agent Products, Services and Solutions
5.1.4 Johnson & Johnson Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnson Recent Developments
5.2 BD
5.2.1 BD Profile
5.2.2 BD Main Business
5.2.3 BD Biodegradable Hemostatic Agent Products, Services and Solutions
5.2.4 BD Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.2.5 BD Recent Developments
5.3 Baxter
5.3.1 Baxter Profile
5.3.2 Baxter Main Business
5.3.3 Baxter Biodegradable Hemostatic Agent Products, Services and Solutions
5.3.4 Baxter Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.3.5 B.Braun Recent Developments
5.4 B.Braun
5.4.1 B.Braun Profile
5.4.2 B.Braun Main Business
5.4.3 B.Braun Biodegradable Hemostatic Agent Products, Services and Solutions
5.4.4 B.Braun Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.4.5 B.Braun Recent Developments
5.5 Cura Medical
5.5.1 Cura Medical Profile
5.5.2 Cura Medical Main Business
5.5.3 Cura Medical Biodegradable Hemostatic Agent Products, Services and Solutions
5.5.4 Cura Medical Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.5.5 Cura Medical Recent Developments
5.6 GELITA MEDICAL
5.6.1 GELITA MEDICAL Profile
5.6.2 GELITA MEDICAL Main Business
5.6.3 GELITA MEDICAL Biodegradable Hemostatic Agent Products, Services and Solutions
5.6.4 GELITA MEDICAL Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.6.5 GELITA MEDICAL Recent Developments
5.7 Curasan AG
5.7.1 Curasan AG Profile
5.7.2 Curasan AG Main Business
5.7.3 Curasan AG Biodegradable Hemostatic Agent Products, Services and Solutions
5.7.4 Curasan AG Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.7.5 Curasan AG Recent Developments
5.8 Meril Life Sciences
5.8.1 Meril Life Sciences Profile
5.8.2 Meril Life Sciences Main Business
5.8.3 Meril Life Sciences Biodegradable Hemostatic Agent Products, Services and Solutions
5.8.4 Meril Life Sciences Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.8.5 Meril Life Sciences Recent Developments
5.9 Zhonghui Shengxi
5.9.1 Zhonghui Shengxi Profile
5.9.2 Zhonghui Shengxi Main Business
5.9.3 Zhonghui Shengxi Biodegradable Hemostatic Agent Products, Services and Solutions
5.9.4 Zhonghui Shengxi Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.9.5 Zhonghui Shengxi Recent Developments
5.10 Beijing Datsing Bio-tech
5.10.1 Beijing Datsing Bio-tech Profile
5.10.2 Beijing Datsing Bio-tech Main Business
5.10.3 Beijing Datsing Bio-tech Biodegradable Hemostatic Agent Products, Services and Solutions
5.10.4 Beijing Datsing Bio-tech Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.10.5 Beijing Datsing Bio-tech Recent Developments
5.11 Guizhou Jin Jiu Biotech
5.11.1 Guizhou Jin Jiu Biotech Profile
5.11.2 Guizhou Jin Jiu Biotech Main Business
5.11.3 Guizhou Jin Jiu Biotech Biodegradable Hemostatic Agent Products, Services and Solutions
5.11.4 Guizhou Jin Jiu Biotech Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.11.5 Guizhou Jin Jiu Biotech Recent Developments
5.12 Beijing Taikesiman
5.12.1 Beijing Taikesiman Profile
5.12.2 Beijing Taikesiman Main Business
5.12.3 Beijing Taikesiman Biodegradable Hemostatic Agent Products, Services and Solutions
5.12.4 Beijing Taikesiman Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.12.5 Beijing Taikesiman Recent Developments
5.13 Foryou Medical
5.13.1 Foryou Medical Profile
5.13.2 Foryou Medical Main Business
5.13.3 Foryou Medical Biodegradable Hemostatic Agent Products, Services and Solutions
5.13.4 Foryou Medical Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.13.5 Foryou Medical Recent Developments
5.14 Saikesaisi Holdings Group
5.14.1 Saikesaisi Holdings Group Profile
5.14.2 Saikesaisi Holdings Group Main Business
5.14.3 Saikesaisi Holdings Group Biodegradable Hemostatic Agent Products, Services and Solutions
5.14.4 Saikesaisi Holdings Group Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.14.5 Saikesaisi Holdings Group Recent Developments
5.15 Biotemed
5.15.1 Biotemed Profile
5.15.2 Biotemed Main Business
5.15.3 Biotemed Biodegradable Hemostatic Agent Products, Services and Solutions
5.15.4 Biotemed Biodegradable Hemostatic Agent Revenue (US$ Million) & (2018-2023)
5.15.5 Biotemed Recent Developments
6 North America
6.1 North America Biodegradable Hemostatic Agent Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Biodegradable Hemostatic Agent Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biodegradable Hemostatic Agent Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biodegradable Hemostatic Agent Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biodegradable Hemostatic Agent Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biodegradable Hemostatic Agent Market Dynamics
11.1 Biodegradable Hemostatic Agent Industry Trends
11.2 Biodegradable Hemostatic Agent Market Drivers
11.3 Biodegradable Hemostatic Agent Market Challenges
11.4 Biodegradable Hemostatic Agent Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
